Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
601 JPY | -0.50% | -1.31% | -12.65% |
Business Summary
Number of employees: 67
Sales per Business
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 2,918 | 100.0 % | 1,901 | 100.0 % | -34.85% |
Sales per region
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
57.4
%
| 1,142 | 39.1 % | 1,091 | 57.4 % | -4.52% |
Asia
42.1
%
| 1,034 | 35.4 % | 801 | 42.1 % | -22.55% |
Japan
0.3
%
| 742 | 25.4 % | 6 | 0.3 % | -99.18% |
Other
0.2
%
| - | - | 4 | 0.2 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Director/Board Member | 52 | 31/12/13 | |
Shuzo Watanabe
BRD | Director/Board Member | 57 | 30/06/08 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 76 | 25/03/20 | |
Shuzo Watanabe
BRD | Director/Board Member | 57 | 30/06/08 |
Yuichi Kakinuma
BRD | Director/Board Member | 46 | 24/03/21 |
Director/Board Member | 52 | 31/12/13 | |
Kosuke Ishii
BRD | Director/Board Member | 41 | 24/03/21 |
Megumi Uzu
BRD | Director/Board Member | 63 | 24/03/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 21,638,281 | 17,062,130 ( 78.85 %) | 51 ( 0.000236 %) | 78.85 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
ADVANCED MEDIA, INC. 1.36% | 250,800 | 1.36% | 2,730,969 $ |
15,267 | 0.00% | 248,547 $ |
Company contact information
RaQualia Pharma, Inc.
Meieki Southside Square, 8/F 1-21-19 Meikei Minami
450-0003, Nagoya
+
http://www.raqualia.co.jpSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.65% | 82.93M | |
+33.25% | 699B | |
+28.59% | 571B | |
-3.55% | 364B | |
+18.16% | 326B | |
+4.36% | 286B | |
+14.81% | 236B | |
+4.93% | 198B | |
-9.78% | 194B | |
-3.69% | 149B |
- Stock Market
- Equities
- 4579 Stock
- Company RaQualia Pharma Inc.